Edward Grahame | BioPharma Services Alliance Manager
Cytiva

I am responsible for connecting nucleic-acid drug developers with Cytiva’s LNP delivery platform. I leverage over 10 years’ experience in nanomedicine vaccine development. I completed my PhD in 2016 from the University of Glasgow on the improvement of bacterial vaccines againts respiratory pathogens. After my PhD, I worked for several years for a biotherapeutic start-up company developing nanomedicine drug prodcuts for various respiratory diseases, my role concerned advancement of the company’s formulation design, CMC activities and pre-clinical testing. At the onset of the COVID-19 pandemic, I took up a position at Cytiva in the development of saRNA-LNP vaccines and since 2022 I have been facilitating access to our LNP technology platform for delivery of nucleic acid therapies and vaccines.